Safety and Curative Efficacy of Sustained-Release Fluorourancil During Radical Laparoscopic Surgery of Rectal Carcinoma: Clinical Observations

LI Song-yan,CHEN Lin,NING Ning,XU Sheng-jiang,LI Rong,DU Xiao-hui
2011-01-01
Abstract:Objective To study the safety and curative effect of sustained-release fluorourancil during laparoscopic rectal carcinoma surgery.Methods One hundred and seventy-two patients with rectal carcinoma who underwent laparoscopic radical surgery in our department from March 2006 to January 2009 were divided into observation group(n=90) and control group(n=82).Patients in observation group received regional chemotherapy with sustained-release fluorourancil under laparoscope.Patients in control group did not receive regional chemotherapy with sustained-release fluorourancil under laparoscope.Their outcomes were retrospectively analyzed.Results No difference was found in liver and kidney functions and white blood cell count between the two groups before and after operation(P0.05).The local recurrence rate of rectal carcinoma was 1.11%(1/90) and 7.78%(7/90) respectively in observation group,and 8.54%(7/82) and 17.07%(14/82) respectively in control group 1 and 2 years after operation(P0.05).The liver metastasis rate was 5.55%(5/90) and 17.78%(16/90) respectively in observation group,and 15.85%(13/82) and 26.83%(22/82) respectively in control group 1 and 2 years after operation(P0.05).Conclusion Sustained-release fluorourancil is effective and safe as a regional chemotherapy agent for rectal carcinoma during laparoscopic radical surgery,and can reduce its local recurrence and liver metastasis.
What problem does this paper attempt to address?